BioCentury | Jan 2, 2012
Financial News

Excelimmune completes venture financing

Excelimmune Inc. , Woburn, Mass. Business: Antibodies, Infectious Date completed: 12/20/11 Type: Venture financing Raised: $12 million Investor: Private investor WIR Staff Infectious...
BioCentury | Jun 6, 2011
Financial News

Excelimmune financial update

...raised in the round to $10.5 million. The company raised $1 million in February 2010. Excelimmune Inc....
BioCentury | Sep 27, 2010
Clinical News

Excelimmune preclinical data

...In mice, Excelimmune's human recombinant polyclonal antibody (HRPA) against MRSA produced 100% survival against doses of...
...antigens. Data were presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Boston. Excelimmune Inc....
Items per page:
1 - 3 of 3
BioCentury | Jan 2, 2012
Financial News

Excelimmune completes venture financing

Excelimmune Inc. , Woburn, Mass. Business: Antibodies, Infectious Date completed: 12/20/11 Type: Venture financing Raised: $12 million Investor: Private investor WIR Staff Infectious...
BioCentury | Jun 6, 2011
Financial News

Excelimmune financial update

...raised in the round to $10.5 million. The company raised $1 million in February 2010. Excelimmune Inc....
BioCentury | Sep 27, 2010
Clinical News

Excelimmune preclinical data

...In mice, Excelimmune's human recombinant polyclonal antibody (HRPA) against MRSA produced 100% survival against doses of...
...antigens. Data were presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Boston. Excelimmune Inc....
Items per page:
1 - 3 of 3